Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SANUWAVE Health, Inc.SNWV · Entity 7321 | Chief Commercial Officer | January 31, 2025 | February 07, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SANUWAVE Health, Inc.
Report date January 31, 2025 · Filed February 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.70 · Expires 2030-01-31 | Direct | 1,571 |
Reported balance
After 2025-01-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-01-31 · Grant · Acquired 1,571 · Balance 1,571 F2: These options were granted in lieu of a portion of the reporting person's 2024 annual cash bonus. F1: Option shares were fully vested at the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Option shares were fully vested at the grant date.
F2: These options were granted in lieu of a portion of the reporting person's 2024 annual cash bonus.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2025 Filed Feb 7, 2025 16:03 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | GrantStock Option (right to buy) · Derivative | 1,571 | $15.67 Strike: $27.70 | $24,617.57 |
DisclosureSEC source: 0001437749-25-003162 · rdgdoc.xml · derivative · entry 1 Gilmore Nanci · CIK 0002028077 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,571 Underlying: Common Stock · 1,571 shares Expires 2030-01-31 F2 · price: These options were granted in lieu of a portion of the reporting person's 2024 annual cash bonus. F1 · derivative.exercise_date: Option shares were fully vested at the grant date. Read SEC document |
| October 22, 2024 Filed Oct 23, 2024 16:15 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | GrantStock Option (right to buy) · Derivative | 74,667 | $0.00 Strike: $14.20 | $0.00 |
DisclosureSEC source: 0001437749-24-031893 · rdgdoc.xml · derivative · entry 1 Gilmore Nanci · CIK 0002028077 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,667 Underlying: Common Stock · 74,667 shares Expires 2034-10-22 F1 · derivative.exercise_date: Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.